Epiducer Lead Delivery System
510(k) K110609
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK110609 | Date24 Jun 2011 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA product code
- LHG
- Device class
- Class II
- Regulation
- 21 CFR Part 882.5880
- Advisory committee
- Neurology
- FDA decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 24 Sep 2026
The Epiducer Lead Delivery System is an electrode, spinal epidural device that functions as an accessory for neurostimulation lead placement. It is designed to introduce Lamitrode S-Series paddle leads and St. Jude Medical Neuromodulation Division percutaneous leads into the epidural space at or below the L1 vertebra.
This device allows for the introduction of S-Series perc-paddle leads and multiple lead arrays through a single percutaneous entry point. The system has received FDA 510(k) clearance and CE Mark approval for use in neurostimulation therapy.
Other devices from St. Jude Medical, Inc.
Questions
AI-generated answers, 24 Sep 2026
What is the primary function of the Epiducer Lead Delivery System?
This device serves as an accessory for neurostimulation lead placement. It is specifically designed to facilitate the introduction of Lamitrode S-Series paddle leads and St. Jude Medical Neuromodulation Division percutaneous leads into the epidural space at or below the L1 vertebra.
Can this system accommodate multiple leads?
Yes, the system is designed to allow for the introduction of S-Series perc-paddle leads and multiple lead arrays through a single percutaneous entry point, which helps streamline the placement process.
What are the regulatory authorizations for this device?
The Epiducer Lead Delivery System has received FDA 510(k) clearance and CE Mark approval for use in neurostimulation therapy, confirming it has been reviewed and authorized for clinical use within those regulatory frameworks.